TP53 Y220C Mutation
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| rosuvastatin | PMV Pharmaceuticals, Inc. (PMVP) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| rezatapopt | PMV Pharmaceuticals, Inc. (PMVP) |
Compare drugs
Frequently asked questions
How many drugs are in development for TP53 Y220C Mutation?
BioSniper tracks 2 drugs in development for TP53 Y220C Mutation across 1 company.
How many clinical trials target TP53 Y220C Mutation?
There are 1 clinical trial targeting TP53 Y220C Mutation tracked by BioSniper.
Deep-dive into TP53 Y220C Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis